Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574067 · ClinicalTrials.gov registry record · Phase 3
Buprenorphine for Prisoners
A Phase 3 study, sponsored by Friends Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 213
- Enrollment target
NCT00574067 is a Phase 3 study that has completed, run by Friends Research Institute. The registered enrollment target is 213 participants.
The verdict
NCT00574067, a Phase 3 study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 213 participants
- Enrollment target
Study Summary
This five-year study examines the effectiveness of buprenorphine treatment provided to previously-addicted inmates(N=320; 160 males, 160 females) initiated in prison and continued in the community. The study also examines the extent to which the setting of post-release buprenorphine is provided.It is expected that participants receiving in-prison buprenorphine will have superior outcomes compared to participants who did not receive in-prison buprenorphine.
Interventions
- DRUG Buprenorphine +OTP
- DRUG Buprenorphine +CHC
- DRUG Counseling +OTP
- DRUG Counseling +CHC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574067
The ClinicalTrials.gov registry entry for NCT00574067 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Friends Research Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Buprenorphine +OTP is the first listed.
NCT00574067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574067 about?
NCT00574067 is a clinical study titled "Buprenorphine for Prisoners". This five-year study examines the effectiveness of buprenorphine treatment provided to previously-addicted inmates(N=320; 160 males, 160 females) initiated in prison and continued in the community. The study also examines the extent to which the setting of post-release buprenorphine is provided.It i...
What is the current status of trial NCT00574067?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 213 participants. The study started on 2008-09. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00574067?
The interventions under investigation include: Buprenorphine +OTP (DRUG), Buprenorphine +CHC (DRUG), Counseling +OTP (DRUG), Counseling +CHC (DRUG).
Who is sponsoring clinical trial NCT00574067?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.